Last reviewed · How we verify
Navoban (TROPISETRON)
Navoban (generic name: TROPISETRON) is a tropisetron drug. It is currently FDA-approved for Chemotherapy-induced nausea and vomiting.
Navoban is a small molecule with a modality of a small molecule. It has been studied in clinical trials for conditions including analgesia, chemotherapy-induced nausea and vomiting, lung cancer, and postoperative nausea and vomiting.
At a glance
| Generic name | TROPISETRON |
|---|---|
| Drug class | tropisetron |
| Target | 5-hydroxytryptamine receptor 3A |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Chemotherapy-induced nausea and vomiting
Common side effects
Key clinical trials
- Effect of CYP2D6 on Perioperative Analgesia of Oxycodone in Elderly Patients
- Effects of Transversus Abdominis Plane Block on Recovery Quality and Maternal-Neonatal Outcomes After Cesarean Delivery (NA)
- Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen (PHASE3)
- Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer (PHASE3)
- Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) (PHASE4)
- Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery (NA)
- Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer (PHASE3)
- Study on the Effects of Multimodal Analgesia Regimens on Postoperative Analgesia and Gastrointestinal Function Recovery After Laparoscopic Abdominal Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Navoban CI brief — competitive landscape report
- Navoban updates RSS · CI watch RSS
Frequently asked questions about Navoban
What is Navoban?
What is Navoban used for?
What is the generic name of Navoban?
What drug class is Navoban in?
What development phase is Navoban in?
What does Navoban target?
Related
- Drug class: All tropisetron drugs
- Target: All drugs targeting 5-hydroxytryptamine receptor 3A
- Therapeutic area: All drugs in Metabolic
- Indication: Drugs for Chemotherapy-induced nausea and vomiting
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing